Identification of cellular senescence-specific genes by comparative transcriptomics

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Nagano, Taiki ^a   Nakano, Masayuki ^a   Nakashima, Akio ^a   Onishi, Kengo ^a   Yamao, Shunsuke ^a   Enari, Masato ^b   Kikkawa, Ushio ^a   Kamada, Shinji ^a  

^a KOBE UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ETOPOSIDE; PROTEIN P53; TRANSCRIPTOME;

APOPTOSIS; CELL AGING; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; HEP-G2 CELL LINE; HUMAN; IMMUNOBLOTTING; METABOLISM; PROCEDURES; RNA INTERFERENCE; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE; CELL LINE, TUMOR; CELLULAR SENESCENCE; ETOPOSIDE; GENE EXPRESSION PROFILING; HEP G2 CELLS; HUMANS; IMMUNOBLOTTING; RNA INTERFERENCE; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84983246902     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31758     Document Type: Article

References (48)

1. Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1961).
2. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990).
3. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
4. Chen, Q. & Ames, B. N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. USA 91, 4130-4134 (1994).
5. Di Leonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540-2551 (1994).
6. d'Adda di Fagagna, F. Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 8, 512-522 (2008).
7. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463-2479 (2010).
8. Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685-705 (2013).
9. Salama, R., Sadaie, M., Hoare, M. & Narita, M. Cellular senescence and its effector programs. Genes Dev. 28, 99-114 (2014).
10. Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413-431 (2009).
11. Purvis, J. E. et al. p53 dynamics control cell fate. Science 336, 1440-1444 (2012).
12. Schlereth, K. et al. Characterization of the p53 cistrome-DNA binding cooperativity dissects p53's tumor suppressor functions. PLoS Genet. 9, e1003726 (2013).
13. Nikulenkov, F. et al. Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death Differ. 19, 1992-2002 (2012).
14. Menendez, D. et al. Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells. Nucleic Acids Res. 41, 7286-7301 (2013).
15. Brady, C. A. et al. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145, 571-583 (2011).
16. Valente, L. J. et al. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Cell Rep. 3, 1339-1345 (2013).
17. el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
18. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M. & Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98 (1994).
19. Dulic, V., Beney, G. E., Frebourg, G., Drullinger, L. F. & Stein, G. H. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol. Cell. Biol. 20, 6741-6754 (2000).
20. Wyllie, F., Haughton, M., Bartek, J., Rowson, J. & Wynford-Thomas, D. Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21(WAF1) expression. Exp. Cell Res. 285, 236-242 (2003).
21. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9667 (1995).
22. Mirabelli, C. K. et al. Bleomycin and talisomycin sequence-specific strand scission of DNA: a mechanism of double-strand cleavage. Cancer Res. 42, 2779-2785 (1982).
23. Bartek, J. & Lukas, J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429 (2003).
24. Kinoshita, E., Kinoshita-Kikuta, E., Takiyama, K. & Koike, T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol. Cell. Proteomics 5, 749-757 (2006).
25. Hosokawa, T., Saito, T., Asada, A., Fukunaga, K. & Hisanaga, S. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE. Mol. Cell. Proteomics 9, 1133-1143 (2010).
26. Meek, D. W. & Anderson, C. W. Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb. Perspect. Biol. 1, a000950 (2009).
27. Aksoy, O. et al. The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence. Genes Dev. 26, 1546-1557 (2012).
28. Carvajal, L. A., Hamard, P. J., Tonnessen, C. & Manfredi, J. J. E2F7, a novel target, is up-regulated by p53 and mediates DNA damagedependent transcriptional repression. Genes Dev. 26, 1533-1545 (2012).
29. Wheaton, K., Muir, J., Ma, W. & Benchimol, S. BTG2 antagonizes Pin1 in response to mitogens and telomere disruption during replicative senescence. Aging Cell 9, 747-760 (2010).
30. Chau, B. N. et al. Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analyses. Cancer Res. 69, 1368-1374 (2009).
31. Raimondi, I. et al. P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements. PLoS One 8, e69152 (2013).
32. te Poele, R. H., Okorokov, A. L., Jardine, L., Cummings, J. & Joel, S. P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62, 1876-1883 (2002).
33. Walker, P. R. et al. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51, 1078-1085 (1991).
34. Ou, Y. H., Chung, P. H., Sun, T. P. & Shieh, S. Y. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol. Biol. Cell 16, 1684-1695 (2005).
35. Rajagopalan, S., Jaulent, A. M., Wells, M., Veprintsev, D. B. & Fersht, A. R. 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res. 36, 5983-5991 (2008).
36. Tran, D. H. et al. Identification of two promoters for human D-amino acid oxidase gene: implication for the differential promoter regulation mediated by PAX5/PAX2. J. Biochem. 157, 377-387 (2015).
37. Donald, S. P. et al. Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res. 61, 1810-1815 (2001).
38. Pollegioni, L., Piubelli, L., Sacchi, S., Pilone, M. S. & Molla, G. Physiological functions of D-amino acid oxidases: from yeast to humans. Cell. Mol. Life Sci. 64, 1373-1394 (2007).
39. Lu, T. & Finkel, T. Free radicals and senescence. Exp. Cell Res. 314, 1918-1922 (2008).
40. Sen, A., Madhivanan, K., Mukherjee, D. & Aguilar, R. C. The epsin protein family: coordinators of endocytosis and signaling. Biomol. Concepts 3, 117-126 (2012).
41. Rajarajacholan, U. K., Thalappilly, S. & Riabowol, K. The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway. PLoS Biol. 11, e1001502 (2013).
42. Ravikumar, B., Moreau, K. & Rubinsztein, D. C. Plasma membrane helps autophagosomes grow. Autophagy 6, 1184-1186 (2010).
43. Young, A. R. et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 23, 798-803 (2009).
44. Narita, M. et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332, 966-970 (2011).
45. Yonezawa, A., Masuda, S., Katsura, T. & Inui, K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am. J. Physiol. Cell Physiol. 295, C632-C641 (2008).
46. Ashoori, M. & Saedisomeolia, A. Riboflavin (vitamin B2) and oxidative stress: a review. Br. J. Nutr. 111, 1985-1991 (2014).
47. Sayles, P. C. & Johnson, L. L. Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii. Infect. Immun. 64, 3088-3092 (1996).
48. Zhou, B. P. et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3, 245-252 (2001).